What Has Jacob Gotlieb’s New Altium Capital Has to Offer the Healthcare Industry?

Jacob Gotlieb’s experience and success and a healthcare industry have earned him respect and title of titan for the healthcare industry. After successfully running such alternative investment firms in the industry like Merlin Biomed Group and Visium Capital the medical doctor and finance strategist is back with Altium Capital, which promises to disrupt the healthcare industry investment scenes one project at a time.

But why Altium Capital and what big projects has it recently undertaken?

Coming up with Altium Capital

In 1998, Jacob Gotlieb joined Merlin Biomed group, an alternative investment firm specializing in the healthcare industry and headed by Stuart Weisbrod, as a portfolio manager. The hedge fund would, however, wind down in 2005 and this prompted him to start his own health industry investment firm, Visium Capital. The new firm took off rapidly and reached a peak in 2016 with over $8 Billion in assets under management but would also be forced to wind down in early 2017.

Altium capital is, therefore, a continuation of Jacob Gotlieb’s longstanding vision of coming up with one of the most disruptive health investment platform for both his investors and industry players. It specializes in spotting and investing in technologically influenced brands and their equally innovative medical devices and treatment options.

Recent investments

While the company may still be in its developmental stages, this hasn’t stopped it from making bold investment moves including taking up a 5.6% percent stake in Oramed pharmaceuticals. The investment was inspired by Oramed’s development of an oral treatment alternative for diabetes patients that seeks to get them off the hook of the injectables.

Altium capital has also invested in the Dublin-based Amarin Corporation, a pharmaceutical that specializes in the development of drugs that improve cardiovascular health. In its most recent move, Altium, which currently shares office space with Weisbrod’s Iguana Healthcare Partners, has also invested in the replacement therapy inspired Oragenics. The funds are meant to help the pharmaceutical develop and commercialize their antibiotics that take on drug-resistant bacterial strains associated with several infectious diseases.

Sussex Healthcare and Shafik Sachedina

For more than 20 years, Sussex Healthcare has offered care to seniors as well as other adults who require specialized care. The organization runs facilities which are located on the southern coast of England. The organization has two chairmen namely Shafik Sachedina and Shiraz Boghani. The two gentlemen have brought their different backgrounds and skills to Sussex Healthcare. Boghani is actively involved in the hotel industry as a manager while Sachedina has a medical knowledge as a qualified dental surgeon. The two have been able to bring together their experience to Sussex organization for more than ten years and have managed to build a lively as well as award-winning adult care company.

Sussex Healthcare opened its first facility in 1985. Currently, the organization has over 20 facilities that are operating under the umbrella of the company including a daycare and gym facilities as well as full-care residential houses. Moreover, the company not only concentrates on running live-in facilities for elderly people who have Alzheimer or dementia, but also young people who have neurological disabilities and other cognitive problems. The company offers its services to people who are in dire need of care as well as those who have limited options when it comes to caring.

The company has skilled caregivers as well as a support team who are trained and devoted to offering the best services to those who need them. Moreover, the company provides continuing education as well as training to its workers that enable them to deliver the best services.

The services that the Sussex Healthcare offers are based on the philosophy that all the people in their facilities deserve continuous access to social, leisure and recreational activities and not just about the physical health. For the past 20 years, the company has been under the management of the co-chairs Shiraz Boghani and Shafik Sachedina. Shiraz is a successful entrepreneur. He is also involved with splendid Hospitality hotels which have more than 20 hotels.

Born in Dar-es-Salaam, Tanzania, Shafik Sachedina attended University of London’s Guy’s Hospital Dental School where he graduated from in 1975 as a dental surgeon. He is a member of the Ismaili community.

Elysium Health’s Commitment to Produce Supplements that Can Result in Better Health

About Elysium Health

Elysium Health was founded by Dr. Leonard Guarente, who is the director of the Glenn Laboratory for the Science of Aging at MIT. The company’s mission is to help people live healthier for longer by providing consumers access to proactive health options. They work with leading clinicians and scientists. Elysium Health has been able to come up with clinically backed health products by use of advanced science and technology.

Additionally, Elysium Health is committed to providing new products by researching and doing clinical trials whereby the new product can take up to two years to be available in the market.

Visit Elysium Health on Medium.com.

About Basis

With more than 25 years of research behind it, Elysium Health’s first and only product, Basis, is a supplement that supports cellular health. It ensures that the body’s cells maintain substantial levels of NAD+. NAD+ is coenzyme that’s very important for biological processes such as DNA maintenance, regulating circadian rhythms, and energy creation. Medical research has shown that, as people age, there is diminished production of NAD+.

Basis produces two essential compounds that include Pterostilbene and nicotinamide riboside. Elysium Healths’ website advises that Basis be taken on a daily basis. The supplement can be used by adults of all ages, and two capsules should be taken every morning with or without food. Most importantly, Basis does not contain any animal product, flavors, artificial colors, nuts, or gluten, making it suitable for many consumers with dietary restrictions.

Why Basis?

Elysium Health has a board of leading scientists who have contributed breakthrough research in various scientific fields. Also, the product has been put through clinical trials that confirmed a rise in NAD+ levels in those who took the supplement regularly. Even further, the ingredients used by Elysium Health have been tested to ensure people’s safety when taking the supplement, and purity testing is always done by a third party.

Cost of the Product

Elysium Health has an available ongoing subscription of $50 per month, or $270 for six months. People who purchase a single  bottle will spend $60. There are additional options in Elysium Health’s website, where you can choose the most suitable subscription depending on your needs and budget.